biomaterial News
-
Defymed at the annual conference of the European Society for Biomaterials (ESB)
4-8 September: Defymed at the annual conference of the European Society for Biomaterials (ESB). Elisa MAILLARD PEDRACINI, our Chief Scientific Officer and Charles-Thibault BURCEZ, our Chief Product Officer will be present from the 4th to the 9th of September at the annual conference of the European Society for Biomaterials (ESB). The theme of this 32nd edition is “Innovative Biomaterials ...
By Defymed
-
Defymed at the conference of the European Society for Biomaterials
September 5th-9th: Defymed at the conference of the European Society for Biomaterials Last year Defymed attended for the first time to the World Biomaterials Congress which held on December 11-15, 2020 via an excellent virtual platform. This year Defymed confirms its strong interest on biomaterials, improvement performed to process them and how they could be used in conjunction with other ...
By Defymed
-
Steeper Energy has become the latest member of Roundtable on Sustainable Biomaterials!
Copenhagen, Denmark – April 2, 2019 – We’re excited to announce that Steeper Energy has become the latest industry leader to join Roundtable on Sustainable Biomaterials (RSB). By doing so, we intend to prove our commitment to producing sustainable, competitive advanced fuels. “Joining RSB is a critical platform for Steeper Energy to engage with other members and leaders ...
-
Graftys Strengthens Its Management And Operations
Graftys, a French Société Anonyme specialized in the development, manufacturing and commercialization of synthetic orthopedic biomaterials, announced today the appointment of its Chairman of the Board, Gilles Alberici, as Chief Executive Officer, effective January 20, 2016. Aurélien Valet has been appointed deputy CEO. ...
By Graftys
-
Nordson Corporation Announces Earnings Release and Webcast for Third Quarter Fiscal Year 2019
Investors who are interested in listening to the webcast, but are not able to participate during the scheduled time can access the replay by visiting Nordson's website, www.nordson.com/investors. The webcast will be archived until Wednesday, August 28, 2019. Nordson Corporation engineers, manufactures and markets differentiated products and systems used to dispense, apply and control ...
-
Endomedix, Inc. to Present at Upcoming Society For Biomaterials 2019 Annual Meeting
Endomedix, Inc., a developer of unique biosurgical products based on natural biopolymer systems, today announced it will provide the first public presentation of its work at a scientific meeting. The 2019 Annual Meeting is scheduled for April 3-6 in Seattle, Washington. The presentation will provide data and descriptions of the performance of its patented hydrogel biomaterial in a series of ...
-
Alfa Chemistry Materials Presents Itself as a New Supplier of Biomaterials
Known as a supplier of a full range of materials, Alfa Chemistry Materials never forgets its mission to bring the newly emerged novel materials to customers, and now presents itself as a provider of biomaterials, which can be used as blood compatibility materials, soft tissue compatibility materials, hard histocompatibility material, biodegradable materials as well as in high molecular drugs. ...
-
LaunchPad Medical Rebrands as RevBio and Launches an Updated Website
Executives from LaunchPad Medical, Inc. announced that the company has rebranded. Its new name, RevBio, was chosen since it more accurately portrays the objective of developing its revolutionary Tetranite® bone adhesive biomaterial platform. The company has also adapted a tag line "Transforming Bone Repair" which better defines the company's musculoskeletal focus in developing products for ...
By RevBio Inc.
-
Second Patent Issued for Healionics’ Textured STAR Biointerface
Healionics Corporation has received a further patent for its textured STAR Biointerface technology. The United States Patent and Trademark Office issued Patent No. 8,647,393, "Implantable Medical Devices Having Microporous Surface Layers and Method for Reducing Foreign Body Response to the Same.” This new patent extends the scope of 8,372,423 issued to Healionics in February 2013. The STAR ...
By Healionics
-
RevBio Receives Approval from the U.K.’s Regulatory Authority to Initiate a Clinical Trial for an Optimized Formulation of its Dental Bone Adhesive Biomaterial
RevBio, Inc., announced that it has received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient clinical trial to examine the safety and efficacy of immediately stabilized dental implants following tooth extractions using an optimized formulation of Tetranite®, the company’s bone adhesive biomaterial. Dr. Michael R. Norton, ...
By RevBio Inc.
-
Synergy Biomedical Launches BIOSPHERE® MIS II, Next Generation Minimally Invasive Bone Graft Delivery System
Synergy Biomedical, LLC, a developer of innovative biomaterial products, today announced the launching of BIOSPHERE® MIS II, Next Generation Minimally Invasive Bone Graft Delivery System. Synergy continues to add solutions for surgeons with new innovative biomaterial products to an already successful portfolio. Leveraging off the proven success of the first-generation design, BIOSPHERE® ...
-
Withdrawn Standard: ASTM F1251-89(2003) Standard Terminology Relating to Polymeric Biomaterials in Medical and Surgical Devices (Withdrawn 2012)
This terminology covers polymeric biomaterials in medical and surgical devices. Terms are defined as they are used relative to medical and surgical materials and devices. Terms that are generally understood and in ...
-
Synergy Biomedical Announces Publication of Core Scientific Study on Its BioSphere® Bone Graft Technology
Synergy Biomedical, LLC, a developer of innovative bone graft products for spine and orthopedic surgery, announced the publication of a basic science study describing the findings and scientific strategies of controlling the bone formation response of bioactive glass. This study was conducted by Synergy’s founder, Mark Borden Ph.D. and a team of clinical and basic science collaborators, and ...
-
Endomedix publishes ground breaking research and method development for the use of biologically derived polysaccharides in implantable medical devices in peer reviewed journal
Endomedix, Inc. announced today the first of a series of publications of its research and patented technology for a new family of biomaterials based on natural polysaccharides. Appearing in the Journal of Applied Polymer Science, the article, “Reproducible, biocompatible medical materials from biologically derived polysaccharides: Processing and Characterization”, addresses the ...
-
Graftys Announces Creation of an International Implant Registry to Follow up Graftys® HBS and Graftys® QuickSet
Aix-en-Provence, November 16th, 2015 – GRAFTYS SA, a company which develops and commercializes biomaterials used in orthopedic surgery, announces that it has recently established an ambitious Post Marketing Surveillance program, in the form of an internationally based registry of patients who have received implants of GRAFTYS® HBS and GRAFTYS® QuickSet. Both of these advanced ...
By Graftys
-
Nordson Appoints New Members to its Powder Team
Nordson Corporation (NASDAQ-NDSN), a leading supplier of precision powder application technology, has announced the addition of Bill Owens and Art McFadden to its Industrial Coating Systems Group. Owens joins the company as a powder system specialist, and McFadden as a powder application specialist. In his position, Owens will be responsible for powder system sales with existing customers as ...
By Nordson EFD
-
Amyris Receives Roundtable on Sustainable Biomaterials (RSB) Sustainability Certification
Amyris, Inc. (Nasdaq:AMRS) has completed the Roundtable on Sustainable Biomaterials (RSB) certification process and has earned one of the most respected sustainability certifications in the world. Amyris, a leading renewable products company, is one of the first commercial-scale second-generation biomaterial producers and is working with a number of partners to deliver products that include ...
-
Nordson Corporation Board of Directors Authorizes Additional $500 Million for Share Repurchase Program
Nordson Corporation (Nasdaq:NDSN) today announced that its Board of Directors has authorized the repurchase of up to an additional $500 million of the Company’s common shares, adding capacity to the $119 million remaining from its 2015 Board authorization. “The Board’s action reflects continued confidence in the long-term strength of our Company and our ongoing commitment to ...
-
EndoClot Expands GI Hemostasis Portfolio With Launch of EndoClot® Adhesive
EndoClot Plus, Inc., a privately held medical device company founded by surgeons and biomaterial scientists announces the CE approval of EndoClot® Adhesive manufactured by EndoClot Plus Co., Ltd. located in Suzhou, China. The product will be made available for discussion during the upcoming Digestive Disease Week held in Washington DC, June 2-5, 2018. EndoClot® Adhesive is a single-use ...
-
Healionics raises $4.7M equity round to support commercialization of STARgraft vascular graf
Healionics Corporation, a private medical device company, announced today the completion of a $4.7M equity financing round led by Keiretsu Capital. The company also announced the conversion to equity of $5.2M in previously outstanding notes and interest. Healionics is preparing to commercialize its innovative STARgraft vascular graft, designed to provide a safer and more reliable means to access ...
By Healionics
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you